Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RGNX
#2788
REGENXBIO Inc. - Common Stock
9.4
3
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.64%
Monthly Change
-2.28%
6 month change
+8.27%
Year Change
-29.78%
Previous Close
9.3
7
Open
9.4
5
Low
9.3
9
High
9.5
9
Volume
404
Markets
US Stock Market
Healthcare
Biotechnology
RGNX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
42.5 M
42.95 M
43.46 M
44.43 M
50.09 M
51.61 M
66.01 M
Valuation ratios
Enterprise value
1.59 B
1.06 B
870.11 M
780.28 M
329.64 M
708.76 M
632.29 M
Price to earnings ratio
-15.22
11.24
-3.42
-3.05
-1.68
-3.83
-2.67
Price to sales ratio
10.94
3.05
8.52
8.89
4.89
4.36
3.05
Price to cash flow ratio
-31.28
6.56
4.63
3.67
2.21
-5.99
-2.14
Price to book ratio
4.48
1.88
1.86
2.57
1.47
7.23
1.47
Enterprise value to EBITDA ratio
-13.21
6.87
-3.25
-2.9
-1.42
-4.25
-3.75
Profitability ratios
Return on assets %
-0.16
0.11
-0.34
-0.46
-0.49
-0.43
0.06
Return on equity %
-0.29
0.17
-0.54
-0.85
-0.87
-1.89
0.32
Return on invested capital %
-226.49
126.79
-177.57
-257.21
-402.58
-257.59
—
Gross margin %
71.93
89.53
51.61
58.76
67.66
100
100
Operating margin %
-77.14
34.01
-233.2
-297.12
-264.18
-94.58
27.09
EBITDA margin %
-77.84
32.77
-237.38
-297.88
-263.21
-97.79
26.68
Net margin %
-71.98
27.18
-248.68
-291.99
-257.11
-113.75
21.02
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.52
3.98
3.19
2.57
2.69
2.38
2.86
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.26
0.52
0.12
0.13
0.17
0.38
0.3
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.45
4.98
-4.81
-4.99
-3.5
-2.4
-4.72
EBIT per share
-3.2
3.64
-6.09
-6.13
-4.81
-3.13
-3.17
EBITDA per share
-3.23
3.51
-6.2
-6.15
-4.7
-3.23
-3.25
Total debt per share
—
—
—
—
—
—
—
Cash per share
14.02
19.34
13.1
7.18
4.95
4.67
1.99
Net current asset value per share
14.25
11.81
9.64
7.66
5.62
5.45
4.45
Tangible book value per share
10.13
17.4
11.96
7.13
5.24
1.99
1.35
Working capital per share
12.06
8.84
6.62
4.68
3.53
3.16
2.9
Book value per share
10.13
17.4
11.96
7.13
5.24
1.99
1.35
News
RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy
Regenxbio: Sell-Off On Hunter Setback Presents A Risky Buy Opportunity (NASDAQ:RGNX)
Stock Index Futures Climb as Chipmakers Rebound and Bond Yields Fall, U.S. Economic Data in Focus
Stock Indices Finish Mostly Lower on Chipmaker Weakness
Crude Oil Down 3%; XPeng Shares Fall After Q2 Results - XPeng (NYSE:XPEV), Expion360 (NASDAQ:XPON)
Rout in Chipmakers Weighs on Broader Market
Stocks Pressured by Weakness in Chipmakers and AI-Infrastructure Stocks
Why Is Regenxbio Stock Falling Monday? - Regenxbio (NASDAQ:RGNX)
REGENXBIO’s Multi-Catalyst Setup Is Hard To Ignore (Rating Upgrade) (NASDAQ:RGNX)
Regenxbio (RGNX) Beats Q2 Earnings and Revenue Estimates
Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates
New Strong Sell Stocks for July 23rd